Elizabeth Peralta, a Laboratory Technician at The Mount Sinai Hospital, lost 55 pounds in five months and reversed her diagnosis of type 2 diabetes with help from The Diabetes Alliance at the Mount Sinai Health System. The Diabetes Alliance offers Mount Sinai staff and patients personalized diabetes education, nutrition, and counseling and support to achieve their health and wellness goals.
The quick turnaround for Ms. Peralta started in July, after a routine physical with her internist, Laurie Edelman, MD, revealed that her blood sugar level had significantly increased over the prior year, resulting in a diagnosis of uncontrolled type 2 diabetes. Dr. Edelman is an Associate Professor in the Division of General Internal Medicine at Icahn School of Medicine at Mount Sinai. Read more
When Ann Ogden was first diagnosed with kidney cancer in 2001, she had no idea that creating a cooking network for cancer patients would someday become her great life’s work. Ann was, professionally, a fashion designer, but she found her culinary knowledge to be particularly useful while managing the side effects of treatment for a later diagnosed breast cancer. She would swap recipes with other patients, who found her guidance helpful and encouraged her to do more with her skills. In 2007, Cook for Your Life–a website dedicated to providing healthy recipes, cooking tips and nutrition information to cancer survivors–was born. Read more
If you think you eat too much sugar, you probably do, and you’re not alone in satisfying your sweet tooth. This infographic illustrates the extent to which Americans overindulge. On average, Americans consume 765 grams sugar, the equivalent of 17 12-ounce sodas every 5 days. Our typical intake is 22 teaspoons of sugar per day, compared to the American Heart Association recommendation of no more than 9.5 teaspoons. Read more
The Joint Commission, the leading accreditor of health care organizations in the United States, has designated Mount Sinai Beth Israel, Mount Sinai St. Luke’s, and Mount Sinai Roosevelt as “Top Performers on Key Quality Measures,” based on data from 2013.
The “Top Performer” program recognizes institutions for improving performance on evidence-based interventions that increase the likelihood of good medical outcomes for patients with certain conditions. As “Top Performers,” the hospitals will be included in The Joint Commission’s America’s Hospitals: Improving Quality and Safety, an online annual report found at http://bit.ly/1xMz5qM and also on The Joint Commission’s Quality Check® website.
“We have learned that the impossible is possible, and advances are being made that we could not have imagined just a few years ago,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, at the conclusion of the school’s third annual SinaInnovations conference in November.
The conference, which took place on campus Tuesday and Wednesday, November 18 and 19, respectively, focused on breakthroughs in medicine and engineering that improve human health and was sponsored jointly with Mount Sinai’s academic affiliate Rensselaer Polytechnic Institute (RPI).
Researchers at the Icahn School of Medicine at Mount Sinai have received more than $31 million from the National Institutes of Health (NIH) to create three new centers that will study how drugs interact with human cells to increase their effectiveness and decrease side effects.
A new Drug Toxicity Signature Center will be run by Ravi Iyengar, PhD, Dorothy H. and Lewis Rosenstiel Professor, Department of Pharmacology and Systems Therapeutics, who has received a grant totaling $11.6 million from the NIH. By leveraging the U.S. Food and Drug Administration’s (FDA) Adverse Event Reporting System database, the center will develop cell signatures that can be used to predict the effects of certain drugs and drug combinations.
While competing in a 1,500-meter triathlon swim in the Hudson River in August, Chris LaPak, 52, experienced sudden cardiac arrest. A Herculean rescue effort ensued, with first responders moving him quickly from a surfboard to a jet ski to a boat and finally to a pier. Attempts at cardiopulmonary resuscitation (CPR) failed, leaving Mr. LaPak—the president of a pharmaceutical printing company—without a pulse for at least nine minutes before he was finally resuscitated with an automated-external defibrillator.
Charles L. Shapiro, MD, a renowned breast cancer researcher and clinician, has been named Co-Director of the Dubin Breast Center, Director of Translational Breast Cancer Research for the Mount Sinai Health System, and Director of Survivorship Programs at The Tisch Cancer Institute at Mount Sinai.
“As a nationally recognized leader in breast medical oncology and research, Dr. Shapiro will have a pivotal role in advancing breast cancer treatment and care for our patients,” says Elisa Port, MD, Chief of Breast Surgery and Co-Director of the Dubin Breast Center at The Tisch Cancer Institute.
In Herald Square, on Wednesday, October 29—World Stroke Day—staff from The Mount Sinai Hospital, World Stroke Organization, and Covidien provided free blood pressure screenings, answered questions about stroke, and helped launch a global “Take 2…Tell 2” campaign. “This initiative encourages people to educate themselves and others by taking two minutes to learn about stroke risk factors, warning signs, and symptoms, and spending two minutes sharing that information,” says Stephan A. Mayer, MD, Founding Director, Institute for Critical Care Medicine, Icahn School of Medicine at Mount Sinai.
The Louis Armstrong Center for Music and Medicine at Mount Sinai Beth Israel has received a pledge of $100,000 from Music Never Stops: The Tyler Seaman Foundation, in honor of Tyler Seaman, who passed away at the age of 18 from clival chordoma, a rare type of spinal cancer.
Tyler had a passion for music, and his family felt that helping other teens ill with cancer or other serious disease was a fitting way to honor him.